查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012576

视网膜成像设备市场：2026-2032年全球市场预测（按设备类型、连接方式、便携性、应用、最终用户、适应症和分销管道划分）

Retinal Imaging Devices Market by Device Type, Connectivity, Portability, Application, End User, Indication, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年视网膜成像设备市场价值为 41.6 亿美元，预计到 2025 年将成长至 44.7 亿美元，复合年增长率为 8.01%，到 2032 年将达到 77 亿美元。

主要市场统计数据
基准年 2024 41.6亿美元
预计年份：2025年 44.7亿美元
预测年份 2032 77亿美元
复合年增长率 (%) 8.01%

本文重点概述了光学、感测器和软体领域的最新技术创新如何改变了视网膜成像的临床工作流程、诊断和部署过程。

视网膜成像设备已成为现代眼科不可或缺的工具，用于辅助诊断、后续观察和研究视网膜疾病。光学设计、感测器技术和影像处理的进步，使得许多诊断功能得以从专业机构转移到更广泛的临床环境。因此，临床医生能够更早发现和治疗疾病，改善患者预后，并推动社区筛检和远距眼科等新型医疗模式的发展。

对技术创新与医疗保健服务模式的融合进行了深入分析，这些融合正在加速视网膜成像领域的去中心化、互联互通和临床效用。

视网膜成像领域正经历一场变革，主要得益于硬体技术的进步和软体的智慧化发展。高解析度光学同调断层扫描（OCT）和超广角成像技术的各种改进，拓展了临床医生可用的非侵入性可视化手段，而自适应光学和扫描雷射视光技术则在检查环境中实现了细胞和微血管级别的分辨率。同时，影像分析技术的进步，包括用于病变检测和进展监测的检验的机器学习模型，正在将原始影像转化为可操作的临床资讯。

对 2025 年贸易政策调整将如何重塑视网膜成像设备市场的供应链策略、采购经济和服务路径进行实际评估。

关税措施和贸易政策调整的推出可能会对视网膜成像设备的供应链、定价策略和采购决策产生重大影响。 2025年实施的关税调整迫使製造商、经销商和医疗保健系统重新评估其筹资策略、区域製造地和库存管理实务。由于这些设备通常包含来自全球各地的精密光学、感测器和电子元件，进口关税的变化可能会对不同产品系列和型号造成不同的成本压力。

将影像方式、最终用户优先顺序和临床应用连结起来的多层次細項分析，明确了产品定位、实证策略和市场进入重点。

在视网膜成像领域，理解技术细分对于制定产品开发和打入市场策略至关重要。技术细分包括自适应光学成像、眼底成像、光学同调断层扫描(OCT)、眼底镜和超广角成像。在眼底成像方面，彩色眼底照片和数位眼底照片在临床和工作流程方面各有优劣。彩色影像便于临床医生直观解读，而数位方法则可与分析平台无缝整合。光学同调断层扫描(OCT) 本身包括频谱域 OCT、扫描源 OCT 和时域 OCT，每种技术都有不同的穿透深度、速度和解析度特性，以满足特定的诊断需求。

区域比较观点介绍影响美洲、欧洲、中东和非洲以及亚太市场采用的独特赎回、监管和采用驱动因素。

区域趋势持续影响着美洲、欧洲、中东和非洲以及全部区域的市场优先事项和竞争策略。在美洲，受私人和公共保险公司报销模式以及成熟的门诊和医院系统网络的共同推动，买家优先考虑能够支持大规模筛检和远距眼科计画的整合解决方案。因此，希望在美洲市场站稳脚跟的供应商必须展现出互通性、合规性和强大的商业性支援基础。

详细的竞争分析揭示了模式专家、成熟的医学影像公司和软体主导的新参与企业如何透过证据、服务模式和策略伙伴关係来竞争。

视网膜影像领域的竞争格局呈现出多元化的特点，既有成熟的医疗影像公司，也有专业的眼科医疗设备製造商，还有新兴的软体主导参与企业。老字型大小企业凭藉其广泛的临床产品组合、全球服务网络和丰富的监管合规经验，确保与医疗机构建立长期的销售合作关係。相较之下，专业製造商则倾向于透过专注于特定成像模式或特定临床领域，投资于迭代式光学性能改进以及与临床医生伙伴关係，从而在竞争中脱颖而出。

为经营团队提供切实可行的、优先考虑的建议，以协调产品、商业和供应链策略，从而加快产品部署并降低政策带来的风险。

产业领导者应优先专注于三个切实可行的领域，以巩固市场地位并提升临床价值。首先，投资可互通的平台和检验的分析能力，确保设备能够顺利整合到不同的医疗环境中。这将降低医院和门诊中心采用设备的门槛，并加速临床应用。其次，探索灵活的商业模式，例如租赁、计量收费和管理服务，以降低采购壁垒，并解决因贸易政策变化而加剧的总体拥有成本 (TCO) 问题。第三，制定区域打入市场策略，充分考虑当地的监管要求、报销框架和临床推广网络，以优化资源配置并缩短实际部署时间。

对混合方法研究方法进行透明的解释，该方法结合了主要临床访谈、次要技术分析和检验，以检验研究结果及其意义。

本研究采用多层次调查方法，结合一手访谈、二手技术审查和严谨的检验，整合讯息，确保得出可靠的结论。一手研究包括与来自不同医疗机构的临床负责人、生物医学工程师、采购决策者和医疗设备技术人员进行结构化访谈，以了解实际应用中的驱动因素和营运限制。此外，还透过对监管申报文件、临床文献、设备规格和公共卫生倡议的二手审查，补充了上述结论，从而更好地理解该技术的性能和部署模式。

简明总结强调，技术、证据产生和实际商业性实施共同决定哪些创新将永续改变视网膜医学。

视网膜成像领域正处于一个转折点，光学技术创新、软体驱动的智慧技术以及采购趋势的转变正在重新定义视网膜护理的提供方式。影像技术日趋强大且普及，推动了分散式诊断、可扩展筛检和数据驱动型疾病管理的发展。同时，关于「医疗设备软体（SaMD）」法规的明确以及近期贸易政策的调整，为供应商和买家都带来了机会和挑战。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 视网膜影像设备市场：依设备类型划分

  • 眼底摄影机
    • 眼底摄影机
    • 眼底摄影机
  • 光学同调断层扫描（OCT）系统
  • 广域成像系统
  • 扫描雷射眼底镜
  • 视网膜血管造影术系统

第九章 视网膜成像设备市场：连结性

  • 独立系统
  • 网路连线系统
  • 云端连线系统

第十章：视网膜成像设备市场－便携性

  • 桌上型装置
  • 直立式安装设备
  • 手持装置
  • 智慧型手机整合系统

第十一章 视网膜影像设备市场：依应用领域划分

  • 疾病诊断与治疗
  • 研究和推广活动
  • 全身筛检
  • 手术及术前计划

第十二章 视网膜成像设备市场：依最终用户划分

  • 门诊手术中心
  • 医院和诊所
  • 眼科诊所
  • 社区健康检查计划
  • 学术和研究机构

第十三章 视网膜影像设备市场：依适应症划分

  • 糖尿病视网膜病变
  • 视网膜静脉阻塞
  • 青光眼
  • 老龄化黄斑部病变（AMD）
  • 葡萄膜炎和发炎性疾病

第十四章 视网膜成像设备市场：依通路划分

  • 线上销售
  • 线下销售

第十五章 视网膜影像设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 视网膜影像设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 视网膜成像设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国视网膜影像设备市场

第十九章：中国视网膜成像设备市场

第20章 竞争格局

  • 2024年市场集中度分析
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2024 年
  • 2024年产品系列分析
  • 基准分析，2024 年
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Canon Inc.
  • Carl Zeiss AG
  • EssilorLuxottica SA
  • Kowa Company, Ltd.
  • NIDEK Co., Ltd.
  • Nikon Corporation
  • Optomed Plc
  • Topcon Corporation
Product Code: MRR-433C4187C5C4

The Retinal Imaging Devices Market was valued at USD 4.16 billion in 2024 and is projected to grow to USD 4.47 billion in 2025, with a CAGR of 8.01%, reaching USD 7.70 billion by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.16 billion
Estimated Year [2025] USD 4.47 billion
Forecast Year [2032] USD 7.70 billion
CAGR (%) 8.01%

A focused overview of how recent optical, sensor, and software breakthroughs have reshaped clinical workflows, diagnostics, and adoption pathways in retinal imaging

Retinal imaging devices have become indispensable in modern ophthalmic care, powering diagnosis, monitoring, and research into retinal disease. Advances in optical design, sensor technology, and image processing have shifted many diagnostic capabilities from specialized centers into broader clinical settings. As a consequence, clinicians are increasingly able to detect and manage conditions earlier, improving patient outcomes and enabling new models of care such as community screening and teleophthalmology.

Over the past several years, innovations in imaging modalities have converged with software-driven analytics to expand clinical utility. Higher-resolution imaging, faster acquisition times, and non-invasive modalities have reduced patient burden while enhancing diagnostic confidence. Regulatory approvals for novel imaging systems and incremental software enhancements have lowered barriers to clinical integration, prompting healthcare providers to reassess technology portfolios and workflow configurations.

Transitioning from research-only environments to routine clinical deployment requires attention to interoperability, training, reimbursement pathways, and workflow redesign. Consequently, stakeholders must weigh device performance against operational realities, including technician skill mix, integration with electronic health records, and downstream referral protocols. This introduction frames the subsequent analysis by laying out the technical, clinical, and operational drivers that shape adoption and the competitive environment for retinal imaging devices.

An incisive analysis of converging technical innovations and care delivery models that are accelerating decentralization, connectivity, and clinical utility in retinal imaging

The retinal imaging landscape is undergoing transformative shifts driven by both hardware refinement and software intelligence. High-resolution optical coherence tomography variants and ultrawide field imaging are extending the boundaries of what clinicians can visualize non-invasively, while adaptive optics and scanning laser ophthalmoscopy are enabling cellular and microvascular resolution in research settings. Simultaneously, advances in image analysis, including machine learning models validated for lesion detection and progression monitoring, are converting raw images into actionable clinical insights.

These technical advances are altering where and how care is delivered. Diagnostic capabilities that were once confined to tertiary centers are moving into ambulatory surgical centers and community clinics through devices optimized for speed, ergonomics, and ease of use. Furthermore, the integration of imaging with telemedicine platforms and cloud-based workflows is enabling remote screening programs and specialist review, reshaping referral patterns and capacity planning. Payment and reimbursement mechanisms are gradually adapting to these new modalities, which in turn affects procurement timing and prioritization.

In parallel, regulatory authorities are evolving their frameworks for software as a medical device, bringing clarity to validation expectations for algorithmic tools used alongside imaging hardware. Consequently, manufacturers are investing in clinical evidence generation and post-market surveillance to support claims and facilitate wider clinical adoption. Taken together, these shifts are accelerating hybrid models of care where devices, analytics, and connectivity coalesce to improve access and diagnostic precision.

A pragmatic evaluation of how 2025 trade policy adjustments are reshaping supply chain strategy, procurement economics, and service-based pathways across retinal imaging device markets

The introduction of tariff measures and trade policy adjustments can materially influence supply chains, pricing strategies, and procurement decisions for retinal imaging devices. Tariff adjustments enacted in 2025 have prompted manufacturers, distributors, and health systems to reassess sourcing strategies, regional manufacturing footprints, and inventory management practices. As devices comprise precision optical components, sensors, and electronics often sourced globally, changes in import duties can create differential cost pressures across product families and variants.

In response, several suppliers have pursued geographic diversification of manufacturing and assembly operations, evaluating options that mitigate exposure to single-country tariff regimes. These supply chain adjustments are accompanied by contract renegotiations with component suppliers and a reevaluation of total landed cost models. Purchasing organizations are similarly revisiting tender specifications and total cost of ownership calculations, weighing higher unit costs against reliability, warranty terms, and clinical support arrangements.

Importantly, tariff-driven cost impacts have also accelerated interest in modularity and service-based models. Where capital expenditure becomes more complex, service contracts, leasing arrangements, and software-centric licensing offer alternative pathways for healthcare providers to access advanced imaging capabilities without immediate large capital outlay. Over time, sustained policy volatility may spur deeper localization of critical component manufacturing, strategic inventory buffers, and collaborative sourcing consortia to optimize resilience across the retinal imaging value chain.

A layered segmentation analysis linking imaging modalities, end-user priorities, and clinical applications to refine product positioning, evidence strategy, and go-to-market focus

Understanding segmentation is essential to align product development and market engagement strategies in retinal imaging. The technology segmentation covers adaptive optics imaging, fundus imaging, optical coherence tomography, scanning laser ophthalmoscope, and ultrawide field imaging. Within fundus imaging, color fundus photography and digital fundus photography represent distinct clinical and workflow trade-offs, with color imaging providing intuitive clinicians' interpretation and digital variants enabling smoother integration with analytics platforms. Optical coherence tomography itself spans spectral domain OCT, swept source OCT, and time domain OCT, each offering different penetration, speed, and resolution characteristics that map to particular diagnostic needs.

End-user segmentation distinguishes ambulatory surgical centers, hospitals and clinics, and research institutions, each with unique procurement criteria. Ambulatory surgical centers typically prioritize throughput, footprint efficiency, and rapid training curves, while hospitals and clinics emphasize interoperability with hospital information systems, multi-modality capability, and lifecycle service support. Research institutions focus on the highest technical specifications and extensibility for experimental protocols, often accepting higher complexity for advanced imaging capabilities.

Application segmentation-diagnostic, research, and screening-further refines product positioning. Diagnostic applications demand validated performance, robust quality controls, and clinician-friendly outputs. Research applications prize customization, raw data access, and modularity. Screening programs emphasize cost-effectiveness, automation, and seamless referral pathways. Crosswalking these segmentation layers enables targeted value propositions, aligning device features, service models, and evidence generation strategies to the needs of each adopter type.

A comparative regional perspective highlighting distinct reimbursement, regulatory, and deployment drivers shaping adoption across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics continue to shape market priorities and competitive approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, purchasers emphasize integrated solutions that support large-scale screening and teleophthalmology initiatives, driven by a mix of private and public payer reimbursement models and an established network of ambulatory and hospital systems. Consequently, vendors seeking traction in the Americas must demonstrate interoperability, regulatory compliance, and strong commercial support infrastructure.

Across Europe, Middle East & Africa, regulatory harmonization in some jurisdictions and variable reimbursement landscapes in others create a heterogeneous environment. Manufacturers need to tailor market entry strategies to local approval pathways and clinical champion networks. The emphasis on value-based care in parts of Europe also elevates the importance of outcomes evidence and cost-effectiveness demonstrations.

The Asia-Pacific region is characterized by rapid adoption in urban centers, a wide variance in healthcare infrastructure, and strong demand for scalable screening solutions to address population-level retinal disease burden. Local manufacturing and partnerships with regional distributors often accelerate market access, while digital health initiatives and public-private screening programs create opportunities for innovative deployment models. In each region, alignment with local clinical needs, regulatory contexts, and procurement norms remains critical to successful adoption.

A nuanced competitive review revealing how modality specialists, established imaging firms, and software-first entrants are competing through evidence, service models, and strategic partnerships

Competitive dynamics in the retinal imaging space are characterized by a mix of established medical imaging firms, specialist ophthalmic device manufacturers, and emergent software-driven entrants. Established firms leverage broad clinical portfolios, global service networks, and deep regulatory experience to secure institutional sales and long-term service contracts. Specialist manufacturers, in contrast, often focus on modality leadership or specific clinical niches, investing in iterative optical improvements and clinician partnerships to differentiate on performance.

Meanwhile, software-first entrants-particularly those focused on image analysis, lesion detection, and workflow automation-are reshaping expectations around device intelligence and downstream value. Partnerships and alliances between hardware vendors and analytics companies have become commonplace as manufacturers seek to embed validated algorithms into their devices or platform offerings. Additionally, contract service providers and third-party integrators play an influential role by enabling scalable deployments across networks of clinics and screening programs.

Across these segments, successful players demonstrate disciplined clinical evidence generation, responsive field service, and flexible commercial models that account for diverse procurement constraints. Strategic activities such as targeted clinical studies, interoperability certifications, and regional distribution partnerships continue to be primary levers by which companies expand adoption and reinforce competitive moats.

Practical and priority-driven recommendations for executives to align product, commercial, and supply chain strategies to accelerate adoption and mitigate policy-driven risks

Industry leaders should prioritize three actionable areas to strengthen market position and deliver clinical value. First, invest in interoperable platforms and validated analytics to ensure devices integrate smoothly into diverse care settings; this reduces friction for hospitals and ambulatory centers and accelerates clinical adoption. Second, explore flexible commercial models such as leasing, pay-per-use, and managed service offerings to lower procurement barriers and address total cost of ownership concerns intensified by trade policy variability. Third, develop region-specific market entry playbooks that account for local regulatory expectations, reimbursement frameworks, and clinical champion networks to optimize resource allocation and shorten time to meaningful adoption.

In parallel, manufacturers should reinforce post-market surveillance and real-world evidence collection to substantiate claims and support regulatory compliance for software-enabled features. Collaborations with research institutions can accelerate validation while also fostering clinician advocacy. Lastly, supply chain resilience must be prioritized through multi-sourcing of critical optics and electronics, strategic inventory buffers, and selective localization strategies to manage exposure to tariff shifts and logistics disruption. Taken together, these actions create a pragmatic roadmap for companies to enhance competitiveness and clinical impact.

A transparent description of a mixed-methods research approach combining primary clinical interviews, secondary technical analysis, and triangulation to validate findings and implications

This research synthesizes information from a layered methodology combining primary interviews, secondary technical review, and rigorous triangulation to ensure robust findings. Primary research included structured discussions with clinical leaders, biomedical engineers, procurement decision-makers, and device technicians across multiple care settings to capture real-world adoption drivers and operational constraints. These insights were complemented by secondary review of regulatory filings, clinical literature, device specifications, and public health initiatives to contextualize technology performance and deployment models.

Data triangulation was applied to reconcile differing perspectives and validate thematic conclusions. Clinical endpoints and workflow impacts were assessed through analysis of peer-reviewed studies and device technical documentation, while supply chain and procurement insights were informed by interviews with manufacturers, distributors, and hospital supply managers. Quality assurance measures included cross-validation of technical claims against independent clinical evaluations and consistency checks with public regulatory records.

This mixed-methods approach ensures that the analysis balances technical accuracy with commercial relevance, producing findings that are both evidence-based and actionable for stakeholders involved in product development, clinical adoption, and strategic planning.

A concise synthesis emphasizing that technology, evidence generation, and pragmatic commercial execution together determine which innovations will sustainably transform retinal care

The retinal imaging arena is at an inflection point where optical innovations, software intelligence, and altered procurement dynamics converge to redefine how retinal care is delivered. Imaging modalities are becoming more capable and accessible, enabling shifts toward decentralized diagnostics, scalable screening, and data-driven disease management. At the same time, evolving regulatory clarity for software-as-a-medical-device and recent trade policy adjustments introduce both opportunities and complexities for suppliers and purchasers.

To navigate this landscape, stakeholders must adopt a dual focus on technological relevance and operational integration. Manufacturers need to design systems that deliver clinical value while minimizing workflow disruption, and healthcare organizations must adapt procurement and training processes to fully capture diagnostic gains. Strategic partnerships, targeted clinical evidence programs, and resilient supply chain configurations will be decisive factors in determining which products and providers gain sustained adoption.

Ultimately, the most successful strategies will combine rigorous clinical validation, flexible commercial models, and regionally informed go-to-market execution, thereby ensuring that advances in retinal imaging translate into measurable improvements in patient care and system efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Retinal Imaging Devices Market, by Device Type

  • 8.1. Fundus Cameras
    • 8.1.1. Mydriatic Fundus Cameras
    • 8.1.2. Non-Mydriatic Fundus Cameras
  • 8.2. Optical Coherence Tomography Systems
  • 8.3. Wide-Field Imaging Systems
  • 8.4. Scanning Laser Ophthalmoscopes
  • 8.5. Retinal Angiography Systems

9. Retinal Imaging Devices Market, by Connectivity

  • 9.1. Standalone Systems
  • 9.2. Networked Systems
  • 9.3. Cloud-Connected Systems

10. Retinal Imaging Devices Market, by Portability

  • 10.1. Tabletop Devices
  • 10.2. Stand-Mounted Devices
  • 10.3. Handheld Devices
  • 10.4. Smartphone-Enabled Systems

11. Retinal Imaging Devices Market, by Application

  • 11.1. Disease Diagnosis & Management
  • 11.2. Research & Outreach
  • 11.3. Systemic Screening
  • 11.4. Surgical & Pre-operative Planning

12. Retinal Imaging Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals & Clinics
  • 12.3. Ophthalmology Clinics
  • 12.4. Community Screening Programs
  • 12.5. Academic & Research Institutes

13. Retinal Imaging Devices Market, by Indication

  • 13.1. Diabetic Retinopathy
  • 13.2. Retinal Vein Occlusion
  • 13.3. Glaucoma
  • 13.4. Age-Related Macular Degeneration (AMD)
  • 13.5. Uveitis & Inflammatory Diseases

14. Retinal Imaging Devices Market, by Distribution Channel

  • 14.1. Online Sales
  • 14.2. Offline Sales

15. Retinal Imaging Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Retinal Imaging Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Retinal Imaging Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Retinal Imaging Devices Market

19. China Retinal Imaging Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2024
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2024
  • 20.3. Product Portfolio Analysis, 2024
  • 20.4. Benchmarking Analysis, 2024
  • 20.5. Alcon Inc.
  • 20.6. Bausch Health Companies Inc.
  • 20.7. Canon Inc.
  • 20.8. Carl Zeiss AG
  • 20.9. EssilorLuxottica SA
  • 20.10. Kowa Company, Ltd.
  • 20.11. NIDEK Co., Ltd.
  • 20.12. Nikon Corporation
  • 20.13. Optomed Plc
  • 20.14. Topcon Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RETINAL IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL RETINAL IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NON-MYDRIATIC FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NON-MYDRIATIC FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NON-MYDRIATIC FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY WIDE-FIELD IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY WIDE-FIELD IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY WIDE-FIELD IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SCANNING LASER OPHTHALMOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SCANNING LASER OPHTHALMOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SCANNING LASER OPHTHALMOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL ANGIOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL ANGIOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL ANGIOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NETWORKED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NETWORKED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NETWORKED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CLOUD-CONNECTED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CLOUD-CONNECTED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CLOUD-CONNECTED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY TABLETOP DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY TABLETOP DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY TABLETOP DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STAND-MOUNTED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STAND-MOUNTED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STAND-MOUNTED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SMARTPHONE-ENABLED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SMARTPHONE-ENABLED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SMARTPHONE-ENABLED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISEASE DIAGNOSIS & MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISEASE DIAGNOSIS & MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISEASE DIAGNOSIS & MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RESEARCH & OUTREACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RESEARCH & OUTREACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RESEARCH & OUTREACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SYSTEMIC SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SYSTEMIC SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SYSTEMIC SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SURGICAL & PRE-OPERATIVE PLANNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SURGICAL & PRE-OPERATIVE PLANNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SURGICAL & PRE-OPERATIVE PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COMMUNITY SCREENING PROGRAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COMMUNITY SCREENING PROGRAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COMMUNITY SCREENING PROGRAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION (AMD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION (AMD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION (AMD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY UVEITIS & INFLAMMATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY UVEITIS & INFLAMMATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY UVEITIS & INFLAMMATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 218. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 222. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 223. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)